Cavendish Capital Markets Ltd. /UK/

  • Market Cap: N/A
  • Industry: Investment Banks/Brokers
  • ISIN: GB00B1FLHR07
GBP
0.29
0.29 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cavendish Capital Markets Ltd. /UK/ stock-summary
stock-summary
Cavendish Capital Markets Ltd. /UK/
Investment Banks/Brokers
Cenkos Securities plc (Cenkos) is a United Kingdom-based independent institutional securities company. The Company's principal activity is institutional stockbroking. Cenkos provides corporate finance, corporate broking, research and execution securities services to small and mid-cap growth companies, and other companies, across a range of industry sectors, as well as investment funds. The Company offers its clients access to equity finance at various stages of their development. The Company's activities also include institutional equities and market making. It provides technical advice on all forms of corporate transactions, including initial public offerings (IPOs), fundraisings, mergers and acquisitions, disposals, restructurings and tender offers. The Company's subsidiaries include Cenkos Nominee UK Limited, Cenkos Securities (Trustees) Limited and Cenkos Securities Asia Pte Limited.
Company Coordinates stock-summary
Company Details
6.7.8 Tokenhouse Yard , LONDON None : EC2R 7AS
stock-summary
Tel: 44 20 73978900
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (3.66%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jeremy Miller
Acting Non-Executive Independent Chairman of the Board
Ms. Lisa Gordon
Non-Executive Chairman of the Board
Mr. James Durkin
Chief Executive Officer, Executive Director
Mr. Julian Morse
Chief Executive Officer, Executive Director
Mr. Andrew Boorman
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Investment Banks/Brokers

stock-summary
Market cap

GBP 16 Million ()

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1,206.90%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

19.76%

stock-summary
Price to Book

0.76